Cargando…

Drug Resistance Genes and Molecular Epidemiological Characteristics of Carbapenem-Resistant Klebsiella pneumonia

BACKGROUND: The global prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) has become a serious challenge for nosocomial infection and attracted worldwide attention. This study explored the drug resistance genes and molecular characteristics for CRKP, providing a reference for nosocomial...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yiqun, Gong, Junjie, Yuan, Xiaoliang, Lu, Hongfei, Jiang, Lixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024906/
https://www.ncbi.nlm.nih.gov/pubmed/36945680
http://dx.doi.org/10.2147/IDR.S399142
_version_ 1784909212040560640
author Liao, Yiqun
Gong, Junjie
Yuan, Xiaoliang
Lu, Hongfei
Jiang, Lixia
author_facet Liao, Yiqun
Gong, Junjie
Yuan, Xiaoliang
Lu, Hongfei
Jiang, Lixia
author_sort Liao, Yiqun
collection PubMed
description BACKGROUND: The global prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) has become a serious challenge for nosocomial infection and attracted worldwide attention. This study explored the drug resistance genes and molecular characteristics for CRKP, providing a reference for nosocomial prevention and control. METHODS: A total of 42 CRKP isolates were collected from the First Affiliated Hospital of Gannan Medical University (Ganzhou, China) from January 2018 to February 2021. The drug resistance of CRKP was tested by the VitekII Compact system. Drug resistance gene expression was detected by poly-merase chain reaction (PCR), and molecular typing was performed by pulsed-field gel electrophoresis (PFGE) and multi-locus sequence typing (MLST). RESULTS: All the 42 CRKP isolates were multi-drug resistant. Among them, 35 isolates (83.3%) produced bla(KPC-2) and 12 isolates (28.6%) produced bla(NDM-1). The detection rate of bla(IMP-4) and bla(OXA-48) was 2.4% (1/42), respectively. Twelve isolates (28.6%) carried both bla(KPC-2) and bla(NDM-1), one isolate (2.4%) carried both bla(KPC-2) and bla(IMP-4), and one isolate (2.4%) carried bla(KPC-2), bla(NDM-1) and bla(OXA-48). A variety of other extended-spectrum beta-lactamases (ESBLs) were also detected. All 42 isolates carried bla(SHV) and bla(CTX-M-1), 27 isolates (64.3%) carried bla(TEM) and 12 isolates (28.6%) carried bla(CTX-M-9). The MLST data classified the 42 CRKP isolates into 11 sequence types, mainly ST11, accounting for 61.9% (26/42), of which 92.3% of isolates (24/26) carrying bla(KPC-2). The PFGE results demonstrated that the 42 CRKP isolates could be divided into 20 clusters A-T, with cluster A (26.2%, 11/42) and cluster H (21.4%, 9/42) dominating, which were all ST11. CONCLUSION: The CRKP isolates were severely multi-drug resistant, and the main resistant gene was bla(KPC-2) production, carrying multiple ESBLs genes simultaneously. The MLST and PFGE revealed that the ST11-bla(KPC-2) Klebsiella pneumoniae was the main clonotype. Our findings may offer help to antibiotics selection and nosocomial infection prevention and control.
format Online
Article
Text
id pubmed-10024906
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-100249062023-03-20 Drug Resistance Genes and Molecular Epidemiological Characteristics of Carbapenem-Resistant Klebsiella pneumonia Liao, Yiqun Gong, Junjie Yuan, Xiaoliang Lu, Hongfei Jiang, Lixia Infect Drug Resist Original Research BACKGROUND: The global prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) has become a serious challenge for nosocomial infection and attracted worldwide attention. This study explored the drug resistance genes and molecular characteristics for CRKP, providing a reference for nosocomial prevention and control. METHODS: A total of 42 CRKP isolates were collected from the First Affiliated Hospital of Gannan Medical University (Ganzhou, China) from January 2018 to February 2021. The drug resistance of CRKP was tested by the VitekII Compact system. Drug resistance gene expression was detected by poly-merase chain reaction (PCR), and molecular typing was performed by pulsed-field gel electrophoresis (PFGE) and multi-locus sequence typing (MLST). RESULTS: All the 42 CRKP isolates were multi-drug resistant. Among them, 35 isolates (83.3%) produced bla(KPC-2) and 12 isolates (28.6%) produced bla(NDM-1). The detection rate of bla(IMP-4) and bla(OXA-48) was 2.4% (1/42), respectively. Twelve isolates (28.6%) carried both bla(KPC-2) and bla(NDM-1), one isolate (2.4%) carried both bla(KPC-2) and bla(IMP-4), and one isolate (2.4%) carried bla(KPC-2), bla(NDM-1) and bla(OXA-48). A variety of other extended-spectrum beta-lactamases (ESBLs) were also detected. All 42 isolates carried bla(SHV) and bla(CTX-M-1), 27 isolates (64.3%) carried bla(TEM) and 12 isolates (28.6%) carried bla(CTX-M-9). The MLST data classified the 42 CRKP isolates into 11 sequence types, mainly ST11, accounting for 61.9% (26/42), of which 92.3% of isolates (24/26) carrying bla(KPC-2). The PFGE results demonstrated that the 42 CRKP isolates could be divided into 20 clusters A-T, with cluster A (26.2%, 11/42) and cluster H (21.4%, 9/42) dominating, which were all ST11. CONCLUSION: The CRKP isolates were severely multi-drug resistant, and the main resistant gene was bla(KPC-2) production, carrying multiple ESBLs genes simultaneously. The MLST and PFGE revealed that the ST11-bla(KPC-2) Klebsiella pneumoniae was the main clonotype. Our findings may offer help to antibiotics selection and nosocomial infection prevention and control. Dove 2023-03-15 /pmc/articles/PMC10024906/ /pubmed/36945680 http://dx.doi.org/10.2147/IDR.S399142 Text en © 2023 Liao et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liao, Yiqun
Gong, Junjie
Yuan, Xiaoliang
Lu, Hongfei
Jiang, Lixia
Drug Resistance Genes and Molecular Epidemiological Characteristics of Carbapenem-Resistant Klebsiella pneumonia
title Drug Resistance Genes and Molecular Epidemiological Characteristics of Carbapenem-Resistant Klebsiella pneumonia
title_full Drug Resistance Genes and Molecular Epidemiological Characteristics of Carbapenem-Resistant Klebsiella pneumonia
title_fullStr Drug Resistance Genes and Molecular Epidemiological Characteristics of Carbapenem-Resistant Klebsiella pneumonia
title_full_unstemmed Drug Resistance Genes and Molecular Epidemiological Characteristics of Carbapenem-Resistant Klebsiella pneumonia
title_short Drug Resistance Genes and Molecular Epidemiological Characteristics of Carbapenem-Resistant Klebsiella pneumonia
title_sort drug resistance genes and molecular epidemiological characteristics of carbapenem-resistant klebsiella pneumonia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024906/
https://www.ncbi.nlm.nih.gov/pubmed/36945680
http://dx.doi.org/10.2147/IDR.S399142
work_keys_str_mv AT liaoyiqun drugresistancegenesandmolecularepidemiologicalcharacteristicsofcarbapenemresistantklebsiellapneumonia
AT gongjunjie drugresistancegenesandmolecularepidemiologicalcharacteristicsofcarbapenemresistantklebsiellapneumonia
AT yuanxiaoliang drugresistancegenesandmolecularepidemiologicalcharacteristicsofcarbapenemresistantklebsiellapneumonia
AT luhongfei drugresistancegenesandmolecularepidemiologicalcharacteristicsofcarbapenemresistantklebsiellapneumonia
AT jianglixia drugresistancegenesandmolecularepidemiologicalcharacteristicsofcarbapenemresistantklebsiellapneumonia